56029-45-9Relevant articles and documents
Organic bifunctional catalyst and preparation method thereof as well as stereoregular biodegradable polyester and preparation method thereof
-
Paragraph 0135-0138, (2021/07/10)
The invention relates to an organic bifunctional catalyst and a preparation method thereof, and stereoregular biodegradable polyester and a preparation method thereof. The organic bifunctional catalyst disclosed by the invention is obtained by reacting isocyanate or isothiocyanate with a pyridylamine compound. According to the catalyst, an O-carboxyl intracyclic anhydride monomer and a pyridine nucleophilic addition monomer of an amino acid source are activated by thiourea, and controllable ring opening polymerization can be performed on an OCA monomer under a mild condition by utilizing an amplification effect of adjacent groups, so that functional polyester with high isotacticity and controllable molecular weight is prepared. The solvent used for polymerization can be chloroform, toluene, dichloromethane and the like, the polymerization temperature range is 25-50 DEG C, and the stereoregularity is adjustable between 60% and 90%. Under the polymerization condition, the monomer conversion rate can reach 99% within 24-48 hours. The molecular weight of the obtained polyester is controllable, and the melting point reaches up to 150 DEG C. The molecular weight of the polyester is changed between 20,000 and 100,000, and the polyester has a wide prospect for industrial application.
Synergetic Organocatalysis for Eliminating Epimerization in Ring-Opening Polymerizations Enables Synthesis of Stereoregular Isotactic Polyester
Tao, Youhua,Li, Maosheng,Tao, Yue,Tang, Jiadong,Wang, Yanchao,Zhang, Xiaoyong,Wang, Xianhong
supporting information, p. 281 - 289 (2019/01/04)
Ring-opening polymerization of O-carboxyanhydrides (OCAs) can furnish polyesters with a diversity of functional groups that are traditionally hard to harvest by polymerization of lactones. Typical ring-opening catalysts are subject to unavoidable racemization of most OCA monomers, which hampers the synthesis of highly isotactic crystalline polymers. Here, we describe an effective bifunctional single-molecule organocatalysis for selective ring-opening polymerization of OCAs without epimerization. The close vicinity of both activating groups in the same molecule engenders an amplified synergetic effect and thus allows for the use of mild bases, thereby leading to minimal epimerization for polymerization. Ring-opening polymerization of manOCA monomer (OCA from mandelic acid) mediated by the bifunctional single-molecule organocatalyst yields highly isotactic poly(mandelic acid) (PMA) with controlled molecular weights (up to 19.8 kg mol-1). Mixing of the two enantiomers of PMA generates the first example of a crystalline stereocomplex in this area, which displayed distinct Tm values around 150 °C. Remarkably, the bifunctional catalysts are moisture-stable, recyclable, and easy to use, allowing sustainable and scalable synthesis of a stereoregular functional polyester.
Metal-free C-H alkylation of heteroarenes with alkyltrifluoroborates: A general protocol for 1°, 2° and 3° alkylation
Matsui, Jennifer K.,Primer, David N.,Molander, Gary A.
, p. 3512 - 3522 (2017/07/10)
A photoredox-catalyzed C-H functionalization of heteroarenes using a variety of primary, secondary, and tertiary alkyltrifluoroborates is reported. Using Fukuzumi's organophotocatalyst and a mild oxidant, conditions amenable for functionalizing complex heteroaromatics are described, providing a valuable tool for late-stage derivatization. The reported method addresses the three major limitations of previously reported photoredox-mediated Minisci reactions: (1) use of superstoichiometric amounts of a radical precursor, (2) capricious regioselectivity, and (3) incorporation of expensive photocatalysts. Additionally, a number of unprecedented, complex alkyl radicals are used, thereby increasing the chemical space accessible to Minisci chemistry. To showcase the application in late-stage functionalization, quinine and camptothecin analogues were synthesized. Finally, NMR studies were conducted to provide a rationalization for the heteroaryl activation that permits the use of a single equivalent of radical precursor and also leads to enhanced regioselectivity. Thus, by 1H and 13C NMR a distinct heteroaryl species was observed in the presence of acid catalyst and BF3.
NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUND
-
Paragraph 0266, (2014/02/15)
There are provided compounds represented by the following general formula (I) or pharmaceutically acceptable salts of thereof, which have a superior monoacylglycerol acyltransferase 2 inhibitory action: wherein Ring A represents a partially saturated heteroaryl group, an aryl group or a heteroaryl group, RB represents a C4-18 alkyl group, a C3-8 cycloalkyl group, a partially saturated aryl group, an aryl group, or the following formula (II): wherein V represents the formula -CR11R12-, -CO-, -CO-O-, or -CO-NH-, W represents a single bond or a C1-3 alkylene group, and Ring B represents a C3-8 cycloalkyl group, a C3-8 cycloalkenyl group, a partially saturated heteroaryl group, a saturated heterocyclyl group, an aryl group, or a heteroaryl group, Y represents a nitrogen atom or the formula N+(RF), RF represents a C1-4 alkyl group, and m and n, which may be the same or different, each represent an integer of 0 or 1.
NEW COMPOUNDS III
-
Page/Page column 35, (2008/06/13)
The present invention relates to new compounds [Chemical formula should be inserted here. Please see paper copy] (I) or salts, solvates or solvated salts thereof, processes for their preparation and to new intermediates used in the preparation thereof, ph
FUSED-ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO
-
Page 229, (2008/06/13)
The present invention relates to certain fused aryl and heteroaryl derivatives of Formula (I) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the prophylaxis or treatment of metabolic disorders and complica